A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. (Q54285640)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
scientific article

    Statements

    A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit